Hemgenix is a single-dose gene therapy product administered via IV infusion. Hemgenix is made up of a viral vector that carries a gene for clotting factor IX. The gene is expressed in the liver to produce Factor IX protein, which raises blood levels of Factor IX. Hemophilia is a rare, inherited blood disorder that causes your blood to clot less quickly, increasing your risk of bleeding or bruising.
Hemophilia Treatment occurs when your body does not produce enough protein (clotting factors) to aid in the formation of blood clots. Clotting factors are proteins found in your blood. They collaborate with your platelets to form blood clots that control bleeding. Low clotting factor levels raise the risk of bleeding. As a result, bleeding episodes will be reduced.
Read More @ https://dailynewsmotion.weebly.com/blog/hemophilia-treatment-used-to-alter-the-missing-blood-clotting-factor
